secwatch.observer — SEC 8-K summary
======================================

Issuer:     Keros Therapeutics, Inc. (KROS)
CIK:        0001664710
Form:       8-K
Filed at:   2025-07-15T23:59:59+00:00
Accession:  0001664710-25-000059
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Keros Therapeutics CMO Yung Chyung resigns effective Aug 1, 2025
----------------------------------------------------------------

- Chief Medical Officer Yung H. Chyung, M.D. resigned effective August 1, 2025.
- Resignation is voluntary and not due to any disagreement with the company.
- Company has initiated a search for a new Chief Medical Officer.
- Dr. Chyung served as CMO and member of the executive team.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1664710/000166471025000059/0001664710-25-000059-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1664710/000166471025000059/kros-20250709.htm
  HTML page:      https://secwatch.observer/filing/0001664710-25-000059

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer